Literature DB >> 2338276

Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests.

U Broomé1, H Glaumann, R Hultcrantz.   

Abstract

Hepatobiliary disorders are well known complications in patients with ulcerative colitis but it is not possible to predict those patients with ulcerative colitis who will eventually develop liver disease. In this study, liver biopsies from 74 patients with ulcerative colitis have been reevaluated. None of the patients showed clinical or biochemical signs of liver disease at the time of biopsy. Thirty seven (50%) had a completely normal liver biopsy. The others showed minimal portal inflammation or fatty infiltration. The biopsies of three patients displayed concentric, periductular fibrosis, or so called 'onion skin' lesions. None showed other signs of fibrosis or cirrhosis. The histological findings were unrelated to either activity or extent of colitis, except for the onion skin lesions which were seen exclusively in biopsies of patients with involvement of the total colon. Sixty eight of the 74 patients were reviewed after a mean interval of 18 years. The majority had no symptoms of hepatobiliary disorders and only two had developed liver disease; one suffered from cryptogenic cirrhosis, possibly due to non-A, non-B hepatitis and the other of an autoimmune liver disease and later developed a bile duct carcinoma. Both were women with total colonic involvement. At the time of the first liver biopsy one showed no histological abnormalities and the other only minor fatty infiltration. Thus, minor abnormalities in liver tissue are common in patients with ulcerative colitis without biochemical evidence of liver disease. The morphological changes are of little help in predicting the future risk of a patient with ulcerative colitis developing a clinically relevant hepatobiliary complication. The absence of biochemical parameters for liver disease during the early years of ulcerative colitis predict a favourable longterm diagnosis as regards hepatobiliary complications.

Entities:  

Mesh:

Year:  1990        PMID: 2338276      PMCID: PMC1378426          DOI: 10.1136/gut.31.4.468

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  PERICHOLANGITIS AND ULCERATIVE COLITIS. I. PATHOLOGY, ETIOLOGY, AND PATHOGENESIS.

Authors:  S P MISTILIS
Journal:  Ann Intern Med       Date:  1965-07       Impact factor: 25.391

2.  The liver in ulcerative colitis.

Authors:  A D Perrett; G Higgins; H H Johnston; G R Massarella; S C Truelove; R Wright
Journal:  Q J Med       Date:  1971-04

3.  Liver disease in ulcerative colitis. I. Analysis of operative liver biopsy in 138 consecutive patients having colectomy.

Authors:  M N Eade
Journal:  Ann Intern Med       Date:  1970-04       Impact factor: 25.391

4.  Clinicopathologic features of the syndrome of primary sclerosing cholangitis.

Authors:  R H Wiesner; N F LaRusso
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

5.  Primary sclerosing cholangitis. A study of forty-two cases.

Authors:  K W Warren; S Athanassiades; J I Monge
Journal:  Am J Surg       Date:  1966-01       Impact factor: 2.565

6.  Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis.

Authors:  M E Thorpe; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1967-10       Impact factor: 23.059

7.  The spectrum of hepatic dysfunction in inflammatory bowel disease.

Authors:  M J Dew; H Thompson; R N Allan
Journal:  Q J Med       Date:  1979-01

8.  Hepatobiliary complications of ulcerative colitis.

Authors:  M Lupinetti; D Mehigan; J L Cameron
Journal:  Am J Surg       Date:  1980-01       Impact factor: 2.565

9.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

Authors:  R W Chapman; B A Arborgh; J M Rhodes; J A Summerfield; R Dick; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

10.  Concurrence of ulcerative colitis and chronic acitve hepatitis, Clinical courses and results of colectomy.

Authors:  R Olsson; L Hultén
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

View more
  7 in total

1.  Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.

Authors:  Rotonya M Carr; Arpan Patel; Hillary Bownik; Amanke Oranu; Caroline Kerner; Amy Praestgaard; Kimberly A Forde; K Rajender Reddy; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2017-03-06       Impact factor: 3.199

2.  Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature.

Authors:  Christopher E McGowan; Patricia Jones; Millie D Long; A Sidney Barritt
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

Review 3.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

4.  Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.

Authors:  Laszlo Lakatos; Tunde Pandur; Gyula David; Zsuzsanna Balogh; Pal Kuronya; Arpad Tollas; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

5.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

6.  Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease.

Authors:  Claudia Veltkamp; Shuai Lan; Eleni Korompoki; Karl-Heinz Weiss; Hartmut Schmidt; Helmut K Seitz
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.241

7.  Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter.

Authors:  Anca Trifan; Remus Stafie; Adrian Rotaru; Ermina Stratina; Sebastian Zenovia; Robert Nastasa; Laura Huiban; Tudor Cuciureanu; Cristina Muzica; Stefan Chiriac; Irina Girleanu; Ana-Maria Singeap; Catalin Sfarti; Camelia Cojocariu; Oana Petrea; Carol Stanciu
Journal:  J Clin Med       Date:  2022-10-09       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.